Melatonin promotes adipogenesis and mitochondrial biogenesis in 3T3-L1 preadipocytes

Journal of Pineal Research

Volumn 59, Issue 2, 2015, Pages 267-275

  Kato, Hisashi ^a   Tanaka, Goki ^a   Masuda, Shinya ^b   Ogasawara, Junetsu ^c   Sakurai, Takuya ^c   Kizaki, Takako ^c   Ohno, Hideki ^c   Izawa, Tetsuya ^a  

^a DOSHISHA UNIVERSITY   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION   (Japan)

^c KYORIN UNIVERSITY   (Japan)

Author keywords

3T3 L1; adipogenesis; adiponectin; melatonin; mitochondrial biogenesis

Indexed keywords

ADIPONECTIN; ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; CITRATE SYNTHASE; FAT DROPLET; MELATONIN; MESSENGER RNA; NUCLEAR RESPIRATORY FACTOR 1; PERILIPIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR A; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 1;

3T3 CELL LINE; ADIPOGENESIS; ANIMAL CELL; ARTICLE; BIOGENESIS; CELL DIFFERENTIATION; CELL VIABILITY; CONTROLLED STUDY; EMBRYO; GENE EXPRESSION; GENE IDENTIFICATION; HORMONE ACTION; HORMONE RELEASE; LIPOLYSIS; MITOCHONDRION; MOUSE; MOUSE EMBRYO; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; DRUG EFFECTS; METABOLISM; SECRETION (PROCESS);

3T3-L1 CELLS; ADIPOGENESIS; ADIPONECTIN; ANIMALS; LIPOLYSIS; MELATONIN; MICE; MITOCHONDRIA; PPAR GAMMA;

EID: 84938420375     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/jpi.12259     Document Type: Article

References (55)

1. Reiter RJ,. Melatonin: the chemical expression of darkness. Mol Cell Endocrinol 1991; 79: C153-C158.
2. Alonso-Vale MI, Andreotti S, Mukai P, et al., Melatonin and the circadian entrainment of metabolic and hormonal activities in primary isolated adipocytes. J Pineal Res 2008; 45: 422-429.
3. Zhang HM, Zhang Y,. Melatonin: a well-documented antioxidant with conditional pro-oxidant actions. J Pineal Res 2014; 57: 131-146.
4. Calvo JR, Gonzalez-Yanes C, Maldonado MD,. The role of melatonin in the cells of the innate immunity: a review. J Pineal Res 2013; 55: 103-120.
5. Slominski AT, Kleszczynski K, Semak L, et al., Local melatoninergic system as the protector of skin integrity. Int J Mol Sci 2014; 15: 17705-17732.
6. Rasmussen DD, Boldt BM, Wilkinson CW, et al., Daily melatonin administration at middle age suppresses male rat visceral fat, plasma leptin, and plasma insulin to youthful levels. Endocrinology 1999; 140: 1009-1012.
7. Puchalski SS, Green JN, Rasmussen DD,. Melatonin effect on rat body weight regulation in response to high-fat diet at middle age. Endocrine 2003; 21: 163-167.
8. Nduhirabandi F, du Toit EF, Blackfurst D, et al., Chronic melatonin consumption prevents obesity-related metabolic abnormalities and protects the heart against myocardial ischemia and reperfusion injury in a prediabetic model of diet-induced obesity. J Pineal Res 2011; 50: 171-182.
9. She M, Deng X, Guo Z, et al., NEU-P11, a novel melatonin agonist, inhibits weight gain and improves insulin sensitivity in high-fat/high-sucrose-fed rats. Pharmacol Res 2009; 59: 248-253.
10. Alonso-Vale MI, Anhê GF, Borges-Silva CN, et al., Pinealectomy alters adipose tissue adaptability to fasting in rats. Metabolism 2004; 53: 500-506.
11. Prunet-Marcassus B, Desbazeille M, Bros A, et al., Melatonin reduces body weight gain in Sprague Dawley rats with diet-induced obesity. Endocrinology 2003; 144: 5347-5352.
12. Robeva R, Kirilov G, Tomova A, et al., Melatonin-insulin interactions in patients with metabolic syndrome. J Pineal Res 2008; 44: 52-56.
13. Peschke E, Frese T, Chankiewitz D, et al., Diabetic Goto Kakizaki rats as well as type 2 diabetic patients show a decreased diurnal serum melatonin level and an increased pancreatic melatonin-receptor status. J Pineal Res 2006; 40: 135-143.
14. McMullan CJ, Achernhammer ES, Rimm EB, et al., Melatonin secretion and the incidence of type 2 diabetes. JAMA 2013; 309: 1388-1396.
15. Borges-Silva CN, Fonseca-Alaniz MH, Alonso-Vale MI, et al., Reduced lipolysis and increased lipogenesis in adipose tissue from pinealectomized rats adapted to training. J Pineal Res 2005; 39: 178-184.
16. Gonzalez A, Alvarez-Garcia V, Martinez-Campa C, et al., Melatonin promotes differentiation of 3T3-L1 fibroblasts. J Pineal Res 2012; 52: 12-20.
17. Maldonado MD, Siu AW, Sanchez-Hidalgo M, et al., Melatonin and lipid uptake by murine fibroblasts: clinical implications. Neuro Endocrinol Lett 2006; 27: 601-608.
18. Alonso-Vale MI, Peres SB, Vernochet C, et al., Adipocyte differentiation is inhibited by melatonin through the regulation of C/EBPbeta transcriptional activity. J Pineal Res 2009; 47: 221-227.
19. Wilson-Fritch L, Burkart A, Bell D, et al., Mitochondrial biogenesis and remodeling during adipogenesis and in response to the insulin sensitizer rosiglitazone. Mol Cell Biol 2003; 23: 1085-1094.
20. Choo HJ, Kim JH, Kwon OB, et al., Mitochondria are impaired in the adipocytes of type 2 diabetic mice. Diabetologia 2006; 49: 784-791.
21. Zavodnik IB, Lapshina EA, Cheshchevik VT, et al., Melatonin and succinate reduce rat liver mitochondrial dysfunction in diabetes. J Physiol Pharmacol 2011; 62: 421-427.
22. Teodoro BG, Baraldi FG, Sampaio IH, et al., Melatonin prevents mitochondrial dysfunction and insulin resistance in rat skeletal muscle. J Pineal Res 2014; 57: 155-167.
23. Jimenéz-Aranda A, Fernández-Váz quez G, Mohammad A-Serrano M,. Melatonin improves mitochondrial function in inguinal white adipose tissue of ZGreek small letter upsilon with dialytikacker diabetic fatty rats. J Pineal Res 2014; 57: 103-109.
24. Kitagawa A, Ohta Y, Ohnishi K,. Melatonin improves metabolic syndrome induced by high fructose intake in rats. J Pineal Res 2012; 52: 403-413.
25. de Oliveira AC, Andrwotti S, Farias TBAS, et al., Metabolic disorders and adipose tissue insulin responsiveness in neonatally STZ-induced diabetic rats are improved by long-term melatonin treatment. Endocrinology 2012; 153: 2178-2188.
26. Koh EH, Park JY, Park HS, et al., Essential role of mitochondrial function in adiponectin synthesis in adipocytes. Diabetes 2007; 56: 2973-2981.
27. Green H, Kehinde O,. An established preadipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion. Cell 1975; 5: 19-27.
28. Park BH, Qiang L, Farmer SR,. Phosphorylation of C/EBPbeta at a consensus extracellular signal-regulated kinase/glycogen synthase kinase 3 site is required for the induction of adiponectin gene expression during the differentiation of mouse fibroblasts into adipocytes. Mol Cell Biol 2004; 24: 8671-8680.
29. Bradfold MM,. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
30. Gaidhu MP, Anthony NM, Patel P, et al., Dysregulation of lipolysis and lipid metabolism in visceral and subcutaneous adipocytes by high-fat diet: role of ATGL, HSL, and AMPK. Am J Physiol Cell Physiol 2010; 298: C961-C971.
31. Rosen ED, Walkey CJ, Puigserver P,. Transcriptional regulation of adipogenesis. Genes Dev 2000; 14: 1293-1307.
32. Ntambi JM, Kim YC,. Adipocyte differentiation and gene expression. J Nutr 2000; 130: 3122S-3126S.
33. Hashimoto T, Segawa H, Okuno M, et al., Active involvement of micro-lipid droplets and lipid-droplet-associated proteins in hormone-stimulated lipolysis in adipocytes. J Cell Sci 2012; 125: 6127-6136.
34. Morak M, Schmidinger H, Riesenhuber G, et al., Adipose triglyceride lipase (ATGL) and hormone-sensitive lipase (HSL) deficiencies affect expression of lipolytic activities in mouse adipose tissues. Mol Cell Proteomics 2012; 11: 1777-1789.
35. Miyoshi H, Perfield JW, Obin MS, et al., Adipose triglyceride lipase regulates basal lipolysis and lipid droplet size in adipocytes. J Cell Biochem 2008; 105: 1430-1436.
36. Maeda N, Takahashi M, Funahashi T, et al., PPAR-gamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 2001; 50: 2094-2099.
37. Kudoh A, Satoh H, Hirai H, et al., Pioglitazone upregulates adiponectin receptor 2 in 3T3-L1 adipocytes. Life Sci 2011; 88: 1055-1062.
38. Yang B, Brown KK, Chen L, et al., Serum adiponectin as a biomarker for in vivo PPARgamma activation and PPARgamma agonist-induced efficacy on insulin sensitization/lipid lowering in rats. BMC Pharmacol 2004; 4: 23.
39. Wang CH, Wang CC, Huang HC, et al., Mitochondrial dysfunction leads to impairment of insulin sensitivity and adiponectin secretion in adipocytes. FEBS J 2013; 280: 1039-1050.
40. Liang H, Ward WF,. PGC-1alpha: a key regulator of energy metabolism. Adv Physiol Educ 2006; 30: 145-151.
41. Huang C, Chen D, Xie Q, et al., Nebivolol stimulates mitochondrial biogenesis in 3T3-L1 adipocytes. Biochem Biophys Res Commun 2013; 438: 211-217.
42. Jimenéz-Aranda A, Fernández-Vázquez G, Campos D, et al., Melatonin induces browning of inguinal white adipose tissue in Zucker diabetic fatty rats. J Pineal Res 2013; 55: 416-423.
43. Mendes C, Lopes AM, Do Amaral FG, et al., Adaptations of the aging animal to exercise: role of daily supplementation with melatonin. J Pineal Res 2013; 55: 229-239.
44. Larsen S, Nielsen J, Hansen CN,. Biomarkers of mitochondrial content in skeletal muscle of healthy young human subjects. J Physiol 2010; 14: 3349-3360.
45. Agabiti-Rosei C, de Ciuceis C, Rossini C, et al., Anticontractile activity of perivascular fat in obese mice and the effect of long-term treatment with melatonin. J Hypertens 2014; 32: 1264-1274.
46. Rong JX, Klein JL, Qiu Y, et al., Rosiglitazone induces mitochondrial biogenesis in differentiated murine 3T3-L1 and C3H/10T1/2 adipocytes. PPAR Res 2011; 2011: 179454.
47. Rong JX, Qiu Y, Hansen MK, et al., Adipose mitochondrial biogenesis is suppressed in db/db and high-fat diet-fed mice and improved by rosiglitazone. Diabetes 2007; 56: 1751-1760.
48. Harms M, Seale P,. Brown and beige fat: development, function and therapeutic potential. Nat Med 2013; 19: 1252-1263.
49. Shabalina IG, Petrovic N, de Jong JM, et al., UCP1 in brite/beige adipose tissue mitochondria is functionally thermogenic. Cell Rep 2013; 5: 1196-1203.
50. Karamanlidis G, Karamitri A, Docherty K, et al., C/EBPβ reprograms white 3T3-L1 preadipocytes to a brown adipocyte pattern of gene expression. J Biol Chem 2007; 282: 24660-24669.
51. Tan DX, Manchester LC, Fuentes-Broto L, et al., Significance and application of melatonin in the regulation of brown adipose tissue metabolism: relation to human obesity. Obes Rev 2011; 12: 167-188.
52. Cipolla-Neto J, Amaral FG, Afeche SC, et al., Melatonin, energy metabolism, and obesity: a review. J Pineal Res 2014; 56: 371-381.
53. Adamczyk-Sowa M, Sowa P, Zwirska-Korczala K, et al., Role of melatonin receptor MT(2) and quinone reductase II in the regulation of the redox status of 3T3-L1 preadipocytes in vitro. Cell Biol Int 2013; 37: 835-842.
54. Zwirska-Korczala K, Jocgem J, Adamczyk-Sowa M, et al., Influence of melatonin on cell proliferation, antioxidative enzyme activities and lipid peroxidation in 3T3-L1 preadipocytes-an in vitro study. J Physiol Pharmacol 2005; 56: 91-99.
55. Wolden-Hanson T, Mitton DR, McCants RL, et al., Daily melatonin administration to middle-aged male rats suppresses body weight, intraabdominal adiposity, and plasma leptin and insulin independent of food intake and total body fat. Endocrinology 2000; 141: 487-497.